Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Jun 15;372(Pt 3):831–839. doi: 10.1042/BJ20021633

Expression of the human oestrogen receptor-alpha gene is regulated by promoter F in MG-63 osteoblastic cells.

Elisabetta Lambertini 1, Letizia Penolazzi 1, Silvia Giordano 1, Laura Del Senno 1, Roberta Piva 1
PMCID: PMC1223453  PMID: 12659635

Abstract

(O)estrogen receptor-alpha (ERalpha), a hormone-dependent transcription factor belonging to the steroid/thyroid-hormone-receptor superfamily, plays an essential role in the development and maintenance of the skeleton. Here we report the analysis of an unexplored sequence inside the bone-specific distal promoter F (PF) with respect to the regulation of ERalpha gene expression in bone. This sequence, 785 bp in size, is localized upstream of the assigned transcription start site of exon F, at -117140 bp from the originally described transcription start site +1. It contains a TA reach box, a conventional CAAT box and potential regulatory elements for many transcription factors, including Cbfa1 [OSE2 (osteoblast-specific element) core binding factor], GATA-1 [(A/T)GATA(A/G) binding protein], Sox5 [sex-determining region Y (SRY)-type HMG bOX protein, belonging to a subfamily of DNA-binding proteins with an HMG domain], Sry, AP1 (activator protein 1) and CP2 (activator of gamma-globin). It is able to strongly activate the luciferase reporter gene in MG-63 osteoblastic-like cells, but not in MCF7 breast-cancer cells. This is in agreement with different transcripts that we found in the two cell types. The footprinting and electrophoretic mobility-shift assays (EMSAs) showed that, inside the region analysed, there were some sequences that specifically reacted to nuclear proteins isolated from MG-63 cells. In particular, we identified two regions, named PF a and PF b, that do not present binding sites for known transcription factors and that are involved in a strong DNA-protein interaction in MG-63, but not in MCF7, cells. The analysis of three transcription factors (GATA-1, Sry and Sox) that might bind the identified footprinted areas suggested a possible indirect role of these proteins in the regulation of ERalpha gene expression in bone. These data provide evidence for different promoter usage of the ERalpha gene through the recruitment of tissue-specific transcription activators and co-regulators.

Full Text

The Full Text of this article is available as a PDF (301.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelman Carrie A., Chattopadhyay Subrata, Bieker James J. The BMP/BMPR/Smad pathway directs expression of the erythroid-specific EKLF and GATA1 transcription factors during embryoid body differentiation in serum-free media. Development. 2002 Jan;129(2):539–549. doi: 10.1242/dev.129.2.539. [DOI] [PubMed] [Google Scholar]
  2. Arts J., Kuiper G. G., Janssen J. M., Gustafsson J. A., Löwik C. W., Pols H. A., van Leeuwen J. P. Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology. 1997 Nov;138(11):5067–5070. doi: 10.1210/endo.138.11.5652. [DOI] [PubMed] [Google Scholar]
  3. Auchus R. J., Fuqua S. A. Hormone-nuclear receptor interactions in health and disease. The oestrogen receptor. Baillieres Clin Endocrinol Metab. 1994 Apr;8(2):433–449. doi: 10.1016/s0950-351x(05)80260-5. [DOI] [PubMed] [Google Scholar]
  4. Bharath M. M. Srinivas, Chandra Nagasuma R., Rao M. R. S. Prediction of an HMG-box fold in the C-terminal domain of histone H1: insights into its role in DNA condensation. Proteins. 2002 Oct 1;49(1):71–81. doi: 10.1002/prot.10204. [DOI] [PubMed] [Google Scholar]
  5. Bianchi N., Passadore M., Feriotto G., Mischiati C., Gambari R., Piva R. Alteration of the expression of human estrogen receptor gene by distamycin. J Steroid Biochem Mol Biol. 1995 Sep;54(5-6):211–215. doi: 10.1016/0960-0760(95)00133-k. [DOI] [PubMed] [Google Scholar]
  6. Bord S., Horner A., Beavan S., Compston J. Estrogen receptors alpha and beta are differentially expressed in developing human bone. J Clin Endocrinol Metab. 2001 May;86(5):2309–2314. doi: 10.1210/jcem.86.5.7513. [DOI] [PubMed] [Google Scholar]
  7. Brand Heike, Kos Martin, Denger Stefanie, Flouriot Gilles, Gromoll Jörg, Gannon Frank, Reid George. A novel promoter is involved in the expression of estrogen receptor alpha in human testis and epididymis. Endocrinology. 2002 Sep;143(9):3397–3404. doi: 10.1210/en.2001-210832. [DOI] [PubMed] [Google Scholar]
  8. Bucher P. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J Mol Biol. 1990 Apr 20;212(4):563–578. doi: 10.1016/0022-2836(90)90223-9. [DOI] [PubMed] [Google Scholar]
  9. Compston J. E. Sex steroids and bone. Physiol Rev. 2001 Jan;81(1):419–447. doi: 10.1152/physrev.2001.81.1.419. [DOI] [PubMed] [Google Scholar]
  10. Denger S., Reid G., Brand H., Kos M., Gannon F. Tissue-specific expression of human ERalpha and ERbeta in the male. Mol Cell Endocrinol. 2001 Jun 10;178(1-2):155–160. doi: 10.1016/s0303-7207(01)00417-8. [DOI] [PubMed] [Google Scholar]
  11. Denger S., Reid G., Kos M., Flouriot G., Parsch D., Brand H., Korach K. S., Sonntag-Buck V., Gannon F. ERalpha gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins. Mol Endocrinol. 2001 Dec;15(12):2064–2077. doi: 10.1210/mend.15.12.0741. [DOI] [PubMed] [Google Scholar]
  12. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 Mar 11;11(5):1475–1489. doi: 10.1093/nar/11.5.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dodig M., Kronenberg M. S., Bedalov A., Kream B. E., Gronowicz G., Clark S. H., Mack K., Liu Y. H., Maxon R., Pan Z. Z. Identification of a TAAT-containing motif required for high level expression of the COL1A1 promoter in differentiated osteoblasts of transgenic mice. J Biol Chem. 1996 Jul 5;271(27):16422–16429. doi: 10.1074/jbc.271.27.16422. [DOI] [PubMed] [Google Scholar]
  14. Donaghue C., Westley B. R., May F. E. Selective promoter usage of the human estrogen receptor-alpha gene and its regulation by estrogen. Mol Endocrinol. 1999 Nov;13(11):1934–1950. doi: 10.1210/mend.13.11.0366. [DOI] [PubMed] [Google Scholar]
  15. Flouriot G., Brand H., Denger S., Metivier R., Kos M., Reid G., Sonntag-Buck V., Gannon F. Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. EMBO J. 2000 Sep 1;19(17):4688–4700. doi: 10.1093/emboj/19.17.4688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Flouriot G., Griffin C., Kenealy M., Sonntag-Buck V., Gannon F. Differentially expressed messenger RNA isoforms of the human estrogen receptor-alpha gene are generated by alternative splicing and promoter usage. Mol Endocrinol. 1998 Dec;12(12):1939–1954. doi: 10.1210/mend.12.12.0209. [DOI] [PubMed] [Google Scholar]
  17. Grandien K. F., Berkenstam A., Nilsson S., Gustafsson J. A. Localization of DNase I hypersensitive sites in the human oestrogen receptor gene correlates with the transcriptional activity of two differentially used promoters. J Mol Endocrinol. 1993 Jun;10(3):269–277. doi: 10.1677/jme.0.0100269. [DOI] [PubMed] [Google Scholar]
  18. Grandien K., Bäckdahl M., Ljunggren O., Gustafsson J. A., Berkenstam A. Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell lines. Endocrinology. 1995 May;136(5):2223–2229. doi: 10.1210/endo.136.5.7720671. [DOI] [PubMed] [Google Scholar]
  19. Green S., Walter P., Kumar V., Krust A., Bornert J. M., Argos P., Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature. 1986 Mar 13;320(6058):134–139. doi: 10.1038/320134a0. [DOI] [PubMed] [Google Scholar]
  20. Kos M., Reid G., Denger S., Gannon F. Minireview: genomic organization of the human ERalpha gene promoter region. Mol Endocrinol. 2001 Dec;15(12):2057–2063. doi: 10.1210/mend.15.12.0731. [DOI] [PubMed] [Google Scholar]
  21. Lambertini E., Penolazzi L., Sollazzo V., Pezzetti F., de Mattei M., del Senno L., Traina G. C., Piva R. Modulation of gene expression in human osteoblasts by targeting a distal promoter region of human estrogen receptor-alpha gene. J Endocrinol. 2002 Mar;172(3):683–693. doi: 10.1677/joe.0.1720683. [DOI] [PubMed] [Google Scholar]
  22. Lambertini Elisabetta, Penolazzi Letizia, Aguiari Gianluca, del Senno Laura, Pezzetti Furio, Sollazzo Vincenzo, Piva Roberta. Osteoblastic differentiation induced by transcription factor decoy against estrogen receptor alpha gene. Biochem Biophys Res Commun. 2002 Apr 5;292(3):761–770. doi: 10.1006/bbrc.2002.6708. [DOI] [PubMed] [Google Scholar]
  23. McPherson L. A., Baichwal V. R., Weigel R. J. Identification of ERF-1 as a member of the AP2 transcription factor family. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4342–4347. doi: 10.1073/pnas.94.9.4342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Moggs J. G., Orphanides G. Estrogen receptors: orchestrators of pleiotropic cellular responses. EMBO Rep. 2001 Sep;2(9):775–781. doi: 10.1093/embo-reports/kve185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Narlikar Geeta J., Fan Hua-Ying, Kingston Robert E. Cooperation between complexes that regulate chromatin structure and transcription. Cell. 2002 Feb 22;108(4):475–487. doi: 10.1016/s0092-8674(02)00654-2. [DOI] [PubMed] [Google Scholar]
  26. Nilsson S., Mäkelä S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., Gustafsson J. A. Mechanisms of estrogen action. Physiol Rev. 2001 Oct;81(4):1535–1565. doi: 10.1152/physrev.2001.81.4.1535. [DOI] [PubMed] [Google Scholar]
  27. Osterlund M. K., Grandien K., Keller E., Hurd Y. L. The human brain has distinct regional expression patterns of estrogen receptor alpha mRNA isoforms derived from alternative promoters. J Neurochem. 2000 Oct;75(4):1390–1397. doi: 10.1046/j.1471-4159.2000.0751390.x. [DOI] [PubMed] [Google Scholar]
  28. Penolazzi L., Lambertini E., Aguiari G., del Senno L., Piva R. Cis element 'decoy' against the upstream promoter of the human estrogen receptor gene. Biochim Biophys Acta. 2000 Jul 24;1492(2-3):560–567. doi: 10.1016/s0167-4781(00)00145-7. [DOI] [PubMed] [Google Scholar]
  29. Ramamurthy L., Barbour V., Tuckfield A., Clouston D. R., Topham D., Cunningham J. M., Jane S. M. Targeted disruption of the CP2 gene, a member of the NTF family of transcription factors. J Biol Chem. 2000 Sep 19;276(11):7836–7842. doi: 10.1074/jbc.M004351200. [DOI] [PubMed] [Google Scholar]
  30. Rickard D. J., Subramaniam M., Spelsberg T. C. Molecular and cellular mechanisms of estrogen action on the skeleton. J Cell Biochem. 1999;Suppl 32-33:123–132. doi: 10.1002/(sici)1097-4644(1999)75:32+<123::aid-jcb15>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  31. Schuur E. R., McPherson L. A., Yang G. P., Weigel R. J. Genomic structure of the promoters of the human estrogen receptor-alpha gene demonstrate changes in chromatin structure induced by AP2gamma. J Biol Chem. 2001 Feb 2;276(18):15519–15526. doi: 10.1074/jbc.M009001200. [DOI] [PubMed] [Google Scholar]
  32. Simon M. C. Transcription factor GATA-1 and erythroid development. Proc Soc Exp Biol Med. 1993 Feb;202(2):115–121. doi: 10.3181/00379727-202-43519a. [DOI] [PubMed] [Google Scholar]
  33. Tang Z., Treilleux I., Brown M. A transcriptional enhancer required for the differential expression of the human estrogen receptor in breast cancers. Mol Cell Biol. 1997 Mar;17(3):1274–1280. doi: 10.1128/mcb.17.3.1274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Terraz C., Toman D., Delauche M., Ronco P., Rossert J. delta Ef1 binds to a far upstream sequence of the mouse pro-alpha 1(I) collagen gene and represses its expression in osteoblasts. J Biol Chem. 2001 Jul 25;276(40):37011–37019. doi: 10.1074/jbc.M104185200. [DOI] [PubMed] [Google Scholar]
  35. Thompson D. A., McPherson L. A., Carmeci C., deConinck E. C., Weigel R. J. Identification of two estrogen receptor transcripts with novel 5' exons isolated from a MCF7 cDNA library. J Steroid Biochem Mol Biol. 1997 Jun;62(2-3):143–153. doi: 10.1016/s0960-0760(97)00029-0. [DOI] [PubMed] [Google Scholar]
  36. Waters K. M., Rickard D. J., Riggs B. L., Khosla S., Katzenellenbogen J. A., Katzenellenbogen B. S., Moore J., Spelsberg T. C. Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform. 2001 Aug 21-Sep 5J Cell Biochem. 83(3):448–462. doi: 10.1002/jcb.1242. [DOI] [PubMed] [Google Scholar]
  37. Wilson Megan, Koopman Peter. Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators. Curr Opin Genet Dev. 2002 Aug;12(4):441–446. doi: 10.1016/s0959-437x(02)00323-4. [DOI] [PubMed] [Google Scholar]
  38. Yang Xiangli, Karsenty Gerard. Transcription factors in bone: developmental and pathological aspects. Trends Mol Med. 2002 Jul;8(7):340–345. doi: 10.1016/s1471-4914(02)02340-7. [DOI] [PubMed] [Google Scholar]
  39. deConinck E. C., McPherson L. A., Weigel R. J. Transcriptional regulation of estrogen receptor in breast carcinomas. Mol Cell Biol. 1995 Apr;15(4):2191–2196. doi: 10.1128/mcb.15.4.2191. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES